Health
09 August 2022, 2:56 pm. 1 minute
Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.
Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Africa
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Sign up for email updates
I'd like to receive communications about Reuters resources, events, products, or services.
(Please note you can manage and update your preferences at any time.)
By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement.By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field
By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field
Sign up for email updates
I'd like to receive communications about Reuters resources, events, products, or services.
(Please note you can manage and update your preferences at any time.)
By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement.By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field
By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field